ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALXO ALX Oncology Holdings

盘前交易 01-13 07:55:03 EST

1.44

+0.09

+6.67%

最高1.49	最低1.37	成交量24.34万
今开1.41	昨收1.35	日振幅8.89%
总市值7,807万	流通市值4,175万	总股本5,422万
成交额34.92万	换手率0.84%	流通股本2,899万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":1.44,"timestamp":1768251600000,"preClose":1.35,"halted":0,"volume":243406,"delay":0,"floatShares":28990900,"shares":54218001,"eps":-2.014895,"marketStatus":"盘前交易","change":0.09,"latestTime":"01-13 07:55:03 EST","open":1.41,"high":1.49,"low":1.37,"amount":349186.523488,"amplitude":0.088889,"askPrice":1.68,"askSize":200,"bidPrice":1.43,"bidSize":2098,"shortable":3,"etf":0,"ttmEps":-2.014895,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768314600000},"marketStatusCode":1,"adr":0,"listingDate":1594958400000,"exchange":"NASDAQ","adjPreClose":1.44,"postHourTrading":{"tag":"盘后","latestPrice":1.44,"preClose":1.44,"latestTime":"19:57 EST","volume":142,"amount":204.4092,"timestamp":1768265876605},"volumeRatio":0.7307926953317614,"impliedVol":2.2005,"impliedVolPercentile":0.72},"requestUrl":"/m/hq/s/ALXO","defaultTab":"news","newsList":[{"id":"2602489582","title":"Alx Oncology Holdings Inc.盘中异动 快速上涨5.65%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602489582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602489582?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:35","pubTimestamp":1767969350,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时35分，Alx Oncology Holdings Inc.股票出现波动，股价大幅上涨5.65%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010922355197a155fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010922355197a155fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"1136686782","title":"ALX Oncology推进评估试验性CD47抑制剂Evorpacept及新型EGFR靶向抗体偶联药物ALX2004的独立临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1136686782","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136686782?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:33","pubTimestamp":1767879222,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings（ALXO）宣布同步推进两项独立临床试验的进展。其中一项试验旨在评估其研发的CD47抑制剂Evorpacept的疗效与安全性，另一项试验则聚焦于新型EGFR靶向抗体偶联药物ALX2004的临床验证。\n这两项试验分别针对不同的肿瘤治疗机制。Evorpacept通过阻断CD47信号通路激活先天免疫系统，ALX2004则利用抗体偶联技术精准靶向EGFR高表达肿瘤细胞。公司表示，临床试验的并行推进将加速创新抗癌疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2601802822","title":"Alx Oncology Holdings Inc.盘中异动 快速拉升5.56%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601802822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601802822?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:48","pubTimestamp":1767797301,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时48分，Alx Oncology Holdings Inc.股票出现波动，股价快速拉升5.56%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.72%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107224821953c294b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107224821953c294b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"1183115403","title":"ALX Oncology公布Evorpacept与标准治疗联合应用于惰性B细胞非霍奇金淋巴瘤患者的积极试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1183115403","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183115403?lang=zh_cn&edition=full","pubTime":"2025-12-07 21:06","pubTimestamp":1765112805,"startTime":"0","endTime":"0","summary":"ALX Oncology公布Evorpacept与标准治疗联合应用于惰性B细胞非霍奇金淋巴瘤患者的积极试验结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2578241570","title":"Alx Oncology Holdings Inc.盘中异动 大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578241570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578241570?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:50","pubTimestamp":1761313835,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时50分，Alx Oncology Holdings Inc.股票出现异动，股价急速上涨5.14%。截至发稿，该股报1.84美元/股，成交量8.0498万股，换手率0.15%，振幅5.14%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215035a6cc36df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024215035a6cc36df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"1115319102","title":"ALX Oncology在2025年AACR-NCI-EORTC会议上宣布Alx2004的前临床数据及I期试验进展报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1115319102","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115319102?lang=zh_cn&edition=full","pubTime":"2025-10-24 00:31","pubTimestamp":1761237070,"startTime":"0","endTime":"0","summary":"ALX Oncology在2025年AACR-NCI-EORTC会议上公布了Alx2004的前临床数据以及I期试验进展报告，这是一种新型的EGFR靶向ADC。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2577806468","title":"Alx Oncology Holdings Inc.盘中异动 大幅上涨5.45%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577806468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577806468?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:30","pubTimestamp":1761053437,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时30分，Alx Oncology Holdings Inc.股票出现异动，股价大幅拉升5.45%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021213037a46c7a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021213037a46c7a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2570080105","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570080105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570080105?lang=zh_cn&edition=full","pubTime":"2025-09-24 22:08","pubTimestamp":1758722903,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日22时08分，Alx Oncology Holdings Inc.股票出现波动，股价快速拉升5.16%。截至发稿，该股报1.33美元/股，成交量5.1018万股，换手率0.10%，振幅2.30%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924220823a4414cae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924220823a4414cae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2569756418","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速下挫5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569756418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569756418?lang=zh_cn&edition=full","pubTime":"2025-09-22 21:37","pubTimestamp":1758548279,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日21时37分，Alx Oncology Holdings Inc.股票出现波动，股价大幅下挫5.78%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213759a72f8822&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922213759a72f8822&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2558266662","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速下跌5.59%报0.639美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558266662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558266662?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:40","pubTimestamp":1754919624,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时40分，Alx Oncology Holdings Inc.股票出现异动，股价急速跳水5.59%。截至发稿，该股报0.639美元/股，成交量2.7287万股，换手率0.05%，振幅4.93%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112140249740e719&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112140249740e719&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2557573302","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557573302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557573302?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:43","pubTimestamp":1754664204,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时43分，Alx Oncology Holdings Inc.股票出现波动，股价大幅下跌5.41%。截至发稿，该股报0.667美元/股，成交量9.7714万股，换手率0.18%，振幅6.00%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080822432594d7e88c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080822432594d7e88c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2557561757","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大跌5.52%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557561757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557561757?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:02","pubTimestamp":1754575365,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日22时02分，Alx Oncology Holdings Inc.股票出现波动，股价大幅跳水5.52%。截至发稿，该股报0.662美元/股，成交量18.9138万股，换手率0.35%，振幅8.23%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807220245a6d9067c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807220245a6d9067c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2557313670","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.33%报0.618美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557313670?lang=zh_cn&edition=full","pubTime":"2025-08-06 00:05","pubTimestamp":1754409914,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日00时05分，Alx Oncology Holdings Inc.股票出现异动，股价大幅上涨5.33%。截至发稿，该股报0.618美元/股，成交量20.7392万股，换手率0.39%，振幅9.03%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为3.27%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600051494d199f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080600051494d199f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2556733836","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556733836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556733836?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:08","pubTimestamp":1754320138,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时08分，Alx Oncology Holdings Inc.股票出现波动，股价急速拉升5.00%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423085894cf1456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423085894cf1456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2556819244","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌6.61%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556819244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556819244?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:30","pubTimestamp":1754055023,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时30分，Alx Oncology Holdings Inc.股票出现波动，股价急速下跌6.61%。截至发稿，该股报0.530美元/股，成交量2.281万股，换手率0.04%，振幅3.52%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213023972cfdf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213023972cfdf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2555402988","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555402988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555402988?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:24","pubTimestamp":1753899861,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时24分，Alx Oncology Holdings Inc.股票出现波动，股价大幅上涨5.47%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102242194c465ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102242194c465ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2554977019","title":"Alx Oncology Holdings Inc.盘中异动 急速拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554977019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554977019?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:42","pubTimestamp":1753713723,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时42分，Alx Oncology Holdings Inc.股票出现异动，股价快速拉升5.59%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728224203a467f1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728224203a467f1e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2552480013","title":"Alx Oncology Holdings Inc.盘中异动 快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552480013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552480013?lang=zh_cn&edition=full","pubTime":"2025-07-17 23:26","pubTimestamp":1752766009,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时26分，Alx Oncology Holdings Inc.股票出现异动，股价快速拉升5.14%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717232649a6b02615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717232649a6b02615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2551840461","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大跌6.07%报0.453美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551840461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551840461?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:59","pubTimestamp":1752501594,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时59分，Alx Oncology Holdings Inc.股票出现波动，股价快速跳水6.07%。截至发稿，该股报0.453美元/股，成交量8.4478万股，换手率0.16%，振幅6.01%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215954a6a8fcba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714215954a6a8fcba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2518274387","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速跳水5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518274387?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:59","pubTimestamp":1741618792,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时59分，Alx Oncology Holdings Inc.股票出现波动，股价急速下挫5.60%。截至发稿，该股报1.00美元/股，成交量42.57万股，换手率0.80%，振幅6.60%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225952abf31d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225952abf31d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alxoncology.com","stockEarnings":[{"period":"1week","weight":0.2857},{"period":"1month","weight":-0.0204},{"period":"3month","weight":-0.1529},{"period":"6month","weight":2.0835},{"period":"1year","weight":-0.1864},{"period":"ytd","weight":0.2743}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ALX Oncology Holdings Inc.于2020年4月1日成立。该公司是一家临床阶段的免疫肿瘤学公司，专注于通过开发阻断CD47免疫检查点和连接先天和适应性免疫系统的疗法来帮助患者对抗癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.065757},{"month":2,"riseRate":0.6,"avgChangeRate":-0.074216},{"month":3,"riseRate":0,"avgChangeRate":-0.227942},{"month":4,"riseRate":0.4,"avgChangeRate":0.062669},{"month":5,"riseRate":0.2,"avgChangeRate":-0.170133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.086057},{"month":7,"riseRate":0.6,"avgChangeRate":0.048848},{"month":8,"riseRate":0.666667,"avgChangeRate":0.169542},{"month":9,"riseRate":0.5,"avgChangeRate":0.033313},{"month":10,"riseRate":0.5,"avgChangeRate":0.033571},{"month":11,"riseRate":0.5,"avgChangeRate":0.074796},{"month":12,"riseRate":0.666667,"avgChangeRate":0.109411}],"exchange":"NASDAQ","name":"ALX Oncology Holdings","nameEN":"ALX Oncology Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ALX Oncology Holdings,ALXO,ALX Oncology Holdings股票,ALX Oncology Holdings股票老虎,ALX Oncology Holdings股票老虎国际,ALX Oncology Holdings行情,ALX Oncology Holdings股票行情,ALX Oncology Holdings股价,ALX Oncology Holdings股市,ALX Oncology Holdings股票价格,ALX Oncology Holdings股票交易,ALX Oncology Holdings股票购买,ALX Oncology Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}